|
Market Closed -
Bombay S.E.
06:02:20 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 1,950.75 INR | -0.40% |
|
+2.11% | +36.99% |
| 08-14 | Ipca Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026 | |
| 08-13 | Ipca Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | |||
| 1,315.04 | +11.96% | 29 | |||||||
| 272.5 | +1.66% | 22 | |||||||
| 276.59 | +8.26% | 29 | |||||||
| 370.31 | +3.24% | 18 | |||||||
| 154.32 | +0.76% | 21 | |||||||
| 212.66 | +31.03% | 22 | |||||||
| 388.48 | -10.16% | 29 | |||||||
| 309.73 | +4.82% | 23 | |||||||
| 157.41 | +8.05% | 27 | |||||||
| 28.61 | +2.31% | 26 | |||||||
| 563.12 | +3.96% | 25 | |||||||
| 66.21 | -0.56% | 24 | |||||||
| 94.28 | +22.04% | 23 | |||||||
| 21.69 | +17.01% | 20 | |||||||
| 9,350 | +32.94% | 15 | |||||||
| 6,515.81 | +12.34% | 16 | |||||||
| 57.39 | +17.91% | 18 | |||||||
| 71.74 | +51.6% | 17 | |||||||
| 4.214 | +14.45% | 17 | |||||||
| Average | 1,064.74 | +12.30% | 22 | ||||||
| Weighted average by Cap. | 710.89 | +8.43% | 24 |
Select your edition
All financial news and data tailored to specific country editions
















